Skip to content
AnalystLens
Back to VRTXCash Flow

VERTEX PHARMACEUTICALS INC / MA Free Cash Flow 2008-2026 | VRTX

Annual FY2008–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$3.19B

+504.1%YoY vs FY2024Source: 10-KFY2025

From −$258.7M in FY2008 to $3.19B in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$1.3B+66.4%Not reportedNot reportedNot reported
FY25$778M−37.2%$927M+124.3%$1.1B−12.5%$349M−29.1%
FY24$1.2B+44.3%−$3.8B−455.7%$1.3B+6.1%$492M+178.8%
FY23$858M−3.9%$1.1B−1.1%$1.2B+36.2%$177M−83.1%
FY22$893M+5.0%$1.1B+535.3%$901M+3.0%$1.0B+12.0%
Share24%31%28%17%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionStable
CAGR

+1.3%

FY2020
$2.99B
FY2025
$3.19B

5 years selected · on the chart

01—History

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

  18. $3.19B
YoY changeLargest recent move+315.2%in FY17Latest +504.1%

4 older moves run past ±150% (largest +504.1%); point at, tap or drag across the bars to read one.

02—Ledger

Free Cash Flow, period by period

PeriodValueChangeSource
FY2025$3.19B+504.1%10-K
FY2024−$790.3M−123.7%10-K
FY2023$3.34B−15.0%10-K
FY2022$3.93B+63.0%10-K
FY2021$2.41B−19.5%10-K
FY2020$2.99B+100.4%10-K
FY2019$1.49B+27.2%10-K
FY2018$1.17B+57.6%10-K
FY2017$745.5M+315.2%10-K
FY2016$179.5M+143.7%10-K
FY2015−$410.7M+34.2%10-K
FY2014−$624.3M−457.1%10-K
FY2013−$112.1M−157.0%10-K
FY2012$196.7M+80.2%10-K
FY2011$109.1M+116.2%10-K
FY2010−$673.5M−49.3%10-K
FY2009−$451.1M−74.4%10-K
FY2008−$258.7M—10-K

03—Questions

What is VERTEX PHARMACEUTICALS INC / MA's current free cash flow?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual free cash flow for 2025 was $3.19B, a 504.13% increase from 2024. VERTEX PHARMACEUTICALS INC / MA free cash flow for the quarter ending March 31, 2026 was $1.29B.

What was VERTEX PHARMACEUTICALS INC / MA's free cash flow in 2024?

VERTEX PHARMACEUTICALS INC / MA annual free cash flow for 2024 was $-790.3M, a 123.68% decline from 2023.

What was VERTEX PHARMACEUTICALS INC / MA's free cash flow in 2023?

VERTEX PHARMACEUTICALS INC / MA annual free cash flow for 2023 was $3.34B, a 14.99% decline from 2022.

What is VERTEX PHARMACEUTICALS INC / MA's 5-year free cash flow CAGR?

VERTEX PHARMACEUTICALS INC / MA free cash flow grew at a compound annual growth rate (CAGR) of 1.30% from FY2020 to FY2025, going from $2.99B to $3.19B over 5 years.

Company
VERTEX PHARMACEUTICALS INC / MA
Ticker
VRTX
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →